EUVIMEDOpdag EUVIMED
ÄquivalenzstudieOpen access · CC BY 4.0

Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation

Ettore Nicolini iD, Antonio Ciacciarelli iD, Giovanni Pracucci, Valentina Saia, Luigi Simonetti, Andrea Zini, Valerio Da Ros, Federica D'agostino, Marta Iacobucci iD, Manuela De Michele, Marco Andrighetti, Rossana Tassi and 40 more

European Journal of Neurology · 2026-07 · 33 (7)

DOI: 10.1111/ene.70682 ↗

At a glance

Äquivalenzstudie in European Journal of Neurology, published online on 2026-07-01. Written by Ettore Nicolini and 51 co-authors. Institution: Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy. Major MEDLINE topics: Thrombolytic Therapy, Thrombectomy, Fibrinolytic Agents, Stroke. 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministero della Salute.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

In the early time window, direct mechanical thrombectomy (MT) is not non‐inferior to combined treatment with intravenous thrombolysis (IVT) for patients with large vessel occlusion (LVO) stroke, while its non‐inferiority in the extended time window remains uncertain. This study assessed whether direct MT is non‐inferior to IVT + MT beyond 4.5 h or at wake‐up.

Methods

We emulated a non‐inferiority trial, comparing direct MT vs. IVT + MT, including patients with anterior circulation LVO between 4.5 and 24 h from symptom onset or at wake‐up, without contraindications to IVT and with target perfusion mismatch. We used inverse probability weighting (IPW) adjusted for pre‐specified covariates. The primary outcome was 90‐day mRS 0–2, with non‐inferiority defined by a lower 95% CI boundary of the Risk Difference (RD) ≥ −1.3%.

Results

Among 347 patients, 212 received direct MT and 135 received IVT + MT. After IPW, patients treated with direct MT and IVT + MT had a similar likelihood of achieving a 90‐day mRS of 0–2 (adjRD –2.90 [95% CI –6.64 to 0.84]) with the lower boundary of the RD 95% CI crossing the non‐inferiority margin. Additionally, direct MT was associated with a shift toward a higher score on the 90‐day mRS (adjusted Common OR 1.59 [95% CI 1.05–2.39]), not confirmed after IPW, and with lower odds of successful recanalization (adjOR 0.38 [95% CI 0.18–0.78]). Rates of 90‐day mRS 0–1, sICH, and mortality were similar between groups.

Conclusions

In our target trial emulation, direct MT was not non‐inferior to IVT + MT treatment beyond 4.5 h from symptom onset or at wake‐up, with IVT before MT yielding higher successful recanalization rates.

Subjects

MeSH terms (MEDLINE)

Thrombolytic TherapyThrombectomyFibrinolytic AgentsStrokeIschemic StrokeHumansFemaleMaleAgedMiddle AgedCombined Modality TherapyTime-to-TreatmentTreatment DelayTime Factors

Author keywords

extended time windowintravenous thrombolysismechanical thrombectomystroke

Substances

Fibrinolytic Agents

Authors and institutions

  • Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
  • Stroke Unit, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Department of NEUROFARBA, Neuroscience Section, University of Florence, Florence, Italy.
  • Neurology and Stroke Unit, S. Corona Hospital, Pietra Ligure, Italy.
  • IRCCS Istituto Di Scienze Neurologiche Di Bologna, Neuroradiology Unit, Maggiore Hospital, Bologna, Italy.
  • IRCCS Istituto Di Scienze Neurologiche Di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Bologna, Italy.

ORCID profiles: Ettore Nicolini, Antonio Ciacciarelli, Marta Iacobucci, Marco Petruzzellis, Andrea Boghi, Danilo Toni

Funding

  • Ministero della Salute

Cite

APA

Nicolini, E., Ciacciarelli, A., Pracucci, G., Saia, V., Simonetti, L., Zini, A., Da Ros, V., D'agostino, F., Iacobucci, M., De Michele, M., Andrighetti, M., Tassi, R., Saletti, A., Casetta, I., Fainardi, E., Pauciulo, A., Caggiula, M., Menozzi, R., Pezzini, A., …, & IRETAS group (2026). Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation. European Journal of Neurology, 33(7). https://doi.org/10.1111/ene.70682

Vancouver

Nicolini E, Ciacciarelli A, Pracucci G, Saia V, Simonetti L, Zini A, et al. Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation. European Journal of Neurology. 2026;33(7). doi:10.1111/ene.70682

BibTeX
@article{Nicolini2026,
  author = {Nicolini, Ettore and Ciacciarelli, Antonio and Pracucci, Giovanni and Saia, Valentina and Simonetti, Luigi and Zini, Andrea and Da Ros, Valerio and D'agostino, Federica and Iacobucci, Marta and De Michele, Manuela and Andrighetti, Marco and Tassi, Rossana and Saletti, Andra and Casetta, Ilaria and Fainardi, Enrico and Pauciulo, Alfredo and Caggiula, Marcella and Menozzi, Roberto and Pezzini, Alessandro and Vallone, Stefano and Bigliardi, Guido and Zimatore, Domenico Sergio and Petruzzellis, Marco and Comai, Alessio and Franchini, Enrica and Allegretti, Luca and Tassinari, Tiziana and Limbucci, Nicola and Nencini, Patrizia and Carità, Giuseppe and Russo, Monia and Filizzolo, Marco and Mannino, Marina and Ruggiero, Maria and Longoni, Marco and Boghi, Andrea and Naldi, Andrea and Bergui, Mauro and Bosco, Giovanni and Pelle, Giuseppe and Alessiani, Michele and Alberti, Matteo and Invernizzi, Paolo and Augelli, Raffaele and Cappellari, Manuel and Lazzarotti, Guido Andrea and Giannini, Nicola and Konda, Daniel and Sallustio, Fabrizio and Mangiafico, Salvatore and Toni, Danilo and IRETAS group, IRETAS group},
  title = {Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {7},
  doi = {10.1111/ene.70682}
}
Start for free →